Clinical Study
Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?
Table 1
Characteristics of patients in the groups.
| Characteristic | Group 1 () | Group 2 () | value |
| Age (y), mean ± SD (range) | 65.4 ± 8.7 (41–88) | 65.3 ± 8.6 (48–86) | 0.812 | Diabetes mellitus (%) | 18 (20.2) | 25 (28.7) | 0.221 | Waist circumference (%) | 39 (43.8) | 45 (5.7) | 0.294 | Hypertension (%) | 25 (28.1) | 30 (34.5) | 0.360 | Metabolic syndrome (%) | 32 (36) | 35 (40.2) | 0.559 | Heart disease (%) | 18 (20.2) | 15 (17.2) | 0.612 | Smoker (%) | 35 (39.3) | 33 (37.9) | 0.849 | LUTS (%) | 31 (34.8) | 35 (40.2) | 0.460 | Previous history of biopsy (%) | 18 (20.2) | 17 (19.5) | 0.909 | PSA level (ng/mL), median (min–max) | 7.20 (2.28–100) | 6.70 (0–150) | 0.293 | Prostate volume median (min–max) | 50 (13–153) | 45 (8–131) | 0.224 | PVR median (min–max) | 15 (0–300) | 15 (0–433) | 0.494 |
|
|